Literature DB >> 8864706

Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts.

F Pasquier1, D Leys, J G Weerts, F Mounier-Vehier, F Barkhof, P Scheltens.   

Abstract

Cerebral atrophy (CA) in stroke patients is associated with poststroke dementia and may reflect underlying neurodegenerative pathology. Therefore, regional CA may be valuable to study in patients who develop poststroke dementia. The aim of this study was to test the reproducibility of a qualitative rating scale of CA on MRI. MRI scans were performed in 50 consecutive patients (age range 19-81) admitted for an acute hemispheric ischemic stroke. CA was assessed on 2 occasions 24 h apart, on axial T2-weighted sequences by 4 independent observers. We evaluated CA in 13 regions on a 0-3 scale. The sum of the subscores was called the CA score (range: 0-39). The level of agreement was expressed by kappa statistics as well as by analysis of variance for interexaminer reproducibility studies. The mean CA scores ranged from 2.8 to 11.0, indicating the low prevalence of CA in this sample. Complete agreement was reached in 41.7% during the first assessment and in 44.1% in the second assessment. The interobserver agreement was moderate in the first session (mean overall kappa: 0.48) and substantial in the second (mean overall kappa: 0.67). The intraobserver agreement was good for all raters (mean kappa: 0.65). Standardized to the range of the scale, standard deviations of the differences between CA scores of the 4 raters in the 2 sessions were 11.1 and 11.2%; within raters it was 4.4%. We conclude that the assessment of CA using this rating scale is possible in stroke patients. It provides regional atrophy measurements and is reproducible when performed by 1 rater.

Entities:  

Mesh:

Year:  1996        PMID: 8864706     DOI: 10.1159/000117270

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  126 in total

1.  Global Cerebral Atrophy Detected by Routine Imaging: Relationship with Age, Hippocampal Atrophy, and White Matter Hyperintensities.

Authors:  Omar M Al-Janabi; Pradeep Panuganti; Erin L Abner; Ahmed A Bahrani; Ronan Murphy; Shoshana H Bardach; Allison Caban-Holt; Peter T Nelson; Brian T Gold; Charles D Smith; Donna M Wilcock; Gregory A Jicha
Journal:  J Neuroimaging       Date:  2018-01-05       Impact factor: 2.486

2.  Small vessel disease in patients with subarachnoid hemorrhage: Prevalence and associations with vasospasm occurrence, severity and clinical outcomes.

Authors:  Adrien Villain; Grégoire Boulouis; Wagih Ben Hassen; Christine Rodriguez-Regent; Denis Trystram; Myriam Edjlali; François Nataf; Xavier Sauvageon; Tarek Sharshar; Jean F Meder; Catherine Oppenheim; Olivier Naggara
Journal:  Neuroradiol J       Date:  2019-09-30

Review 3.  Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia.

Authors:  Nasim Sheikh-Bahaei; Seyed Ahmad Sajjadi; Aimee L Pierce
Journal:  Curr Treat Options Neurol       Date:  2017-11-14       Impact factor: 3.598

4.  Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.

Authors:  Gregoire Boulouis; Andreas Charidimou; Michael J Jessel; Li Xiong; Duangnapa Roongpiboonsopit; Panagiotis Fotiadis; Marco Pasi; Alison Ayres; M Emily Merrill; Kristin M Schwab; Jonathan Rosand; M Edip Gurol; Steven M Greenberg; Anand Viswanathan
Journal:  Neurology       Date:  2017-01-27       Impact factor: 9.910

5.  Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.

Authors:  Ingrid S van Maurik; Marissa D Zwan; Betty M Tijms; Femke H Bouwman; Charlotte E Teunissen; Philip Scheltens; Mike P Wattjes; Frederik Barkhof; Johannes Berkhof; Wiesje M van der Flier
Journal:  JAMA Neurol       Date:  2017-12-01       Impact factor: 18.302

6.  Automatically computed rating scales from MRI for patients with cognitive disorders.

Authors:  Juha R Koikkalainen; Hanneke F M Rhodius-Meester; Kristian S Frederiksen; Marie Bruun; Steen G Hasselbalch; Marta Baroni; Patrizia Mecocci; Ritva Vanninen; Anne Remes; Hilkka Soininen; Mark van Gils; Wiesje M van der Flier; Philip Scheltens; Frederik Barkhof; Timo Erkinjuntti; Jyrki M P Lötjönen
Journal:  Eur Radiol       Date:  2019-02-22       Impact factor: 5.315

7.  Quantitative regional validation of the visual rating scale for posterior cortical atrophy.

Authors:  Christiane Möller; Wiesje M van der Flier; Adriaan Versteeg; Marije R Benedictus; Mike P Wattjes; Esther L G M Koedam; Philip Scheltens; Frederik Barkhof; Hugo Vrenken
Journal:  Eur Radiol       Date:  2013-10-04       Impact factor: 5.315

8.  Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease.

Authors:  W J P Henneman; H Vrenken; J Barnes; I C Sluimer; N A Verwey; M A Blankenstein; M Klein; N C Fox; P Scheltens; F Barkhof; W M van der Flier
Journal:  Neurology       Date:  2009-09-22       Impact factor: 9.910

9.  MRI characteristics and scoring in HDLS due to CSF1R gene mutations.

Authors:  Christina Sundal; Jay A Van Gerpen; Alexandra M Nicholson; Christian Wider; Elizabeth A Shuster; Jan Aasly; Salvatore Spina; Bernardino Ghetti; Sigrun Roeber; James Garbern; Anne Borjesson-Hanson; Alex Tselis; Russell H Swerdlow; Bradley B Miller; Shinsuke Fujioka; Michael G Heckman; Ryan J Uitti; Keith A Josephs; Matt Baker; Oluf Andersen; Rosa Rademakers; Dennis W Dickson; Daniel Broderick; Zbigniew K Wszolek
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

10.  Small vessel versus large vessel vascular dementia: risk factors and MRI findings.

Authors:  S S Staekenborg; E C W van Straaten; W M van der Flier; R Lane; F Barkhof; P Scheltens
Journal:  J Neurol       Date:  2008-07-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.